Literature DB >> 26594908

Noninvasive Detection of Early Metabolic Left Ventricular Remodeling in Systemic Hypertension.

Yasmin S Hamirani1, Bijoy K Kundu, Min Zhong, Andrew McBride, Yinlin Li, Giovanni E Davogustto, Heinrich Taegtmeyer, Jamieson M Bourque.   

Abstract

OBJECTIVES: Hypertension (HTN) is a common cause of left ventricular hypertrophy (LVH). Sustained pressure overload induces a permanent myocardial switch from fatty-acid to glucose metabolism. In this study, we tested the hypothesis that metabolic remodeling, characterized by increased myocardial glucose uptake, precedes structural and functional remodeling in HTN-induced LVH.
METHODS: We recruited 31 patients: 11 with HTN only, 9 with HTN and LVH and 11 normotensive controls without LVH. Transthoracic echocardiography was performed to assess the function, mass, wall thickness and diastolic function of the left ventricle. Positron emission tomography imaging was performed, and the rate of myocardial 2-deoxy-2-[18F]fluoro-D-glucose uptake, Ki, was determined using a 3-compartment kinetic model.
RESULTS: The mean Ki values were significantly higher in HTN patients than in those with HTN and LVH (p < 0.001) and in controls (p = 0.003). The unexpected decrease in Ki with LVH may be secondary to a decreased Ki with diastolic dysfunction (DD), 0.039 ± 0.032 versus 0.072 ± 0.013 (p = 0.004). There was also a significant stepwise decrease in Ki with increasing DD grade (p = 0.04).
CONCLUSION: Glucose metabolic remodeling is detectable in hypertensive patients before the development of LVH. Furthermore, lower glucose uptake rates are observed in patients with DD. The mechanism for this last finding requires further investigation.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26594908      PMCID: PMC4677787          DOI: 10.1159/000441276

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  19 in total

1.  Hypertensive left ventricular hypertrophy is associated with abnormal myocardial fatty acid metabolism and myocardial efficiency.

Authors:  Lisa de las Fuentes; Pablo F Soto; Brian P Cupps; Michael K Pasque; Pilar Herrero; Robert J Gropler; Alan D Waggoner; Victor G Dávila-Román
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

Review 2.  Recent advances in metabolic imaging.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2013-12       Impact factor: 5.952

3.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

4.  Insulin resistance improves metabolic and contractile efficiency in stressed rat heart.

Authors:  Romain Harmancey; Truong N Lam; Genna M Lubrano; Patrick H Guthrie; Deborah Vela; Heinrich Taegtmeyer
Journal:  FASEB J       Date:  2012-05-18       Impact factor: 5.191

Review 5.  Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.

Authors:  Bijoy K Kundu; Min Zhong; Shiraj Sen; Giovanni Davogustto; Susanna R Keller; Heinrich Taegtmeyer
Journal:  Cardiology       Date:  2015-03-12       Impact factor: 1.869

Review 6.  Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes.

Authors:  Christopher J Nolan; Neil B Ruderman; Steven E Kahn; Oluf Pedersen; Marc Prentki
Journal:  Diabetes       Date:  2015-03       Impact factor: 9.461

Review 7.  Insulin resistance protects the heart from fuel overload in dysregulated metabolic states.

Authors:  Heinrich Taegtmeyer; Christophe Beauloye; Romain Harmancey; Louis Hue
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-10-04       Impact factor: 4.733

8.  Quantitative PET imaging detects early metabolic remodeling in a mouse model of pressure-overload left ventricular hypertrophy in vivo.

Authors:  Min Zhong; Clayton E Alonso; Heinrich Taegtmeyer; Bijoy K Kundu
Journal:  J Nucl Med       Date:  2013-02-20       Impact factor: 10.057

9.  Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement.

Authors:  George Petrov; Elke Dworatzek; Tabea Marie Schulze; Michael Dandel; Georgios Kararigas; Shokufeh Mahmoodzadeh; Christoph Knosalla; Roland Hetzer; Vera Regitz-Zagrosek
Journal:  JACC Cardiovasc Imaging       Date:  2014-10-08

10.  Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart.

Authors:  Shiraj Sen; Bijoy K Kundu; Henry Cheng-Ju Wu; S Shahrukh Hashmi; Patrick Guthrie; Landon W Locke; R Jack Roy; G Paul Matherne; Stuart S Berr; Matthew Terwelp; Brian Scott; Sylvia Carranza; O Howard Frazier; David K Glover; Wolfgang H Dillmann; Michael J Gambello; Mark L Entman; Heinrich Taegtmeyer
Journal:  J Am Heart Assoc       Date:  2013-05-17       Impact factor: 5.501

View more
  13 in total

Review 1.  Exercise Intolerance In Heart Failure With Preserved Ejection Fraction.

Authors:  Anisha A Gupte; Dale J Hamilton
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Apr-Jun

Review 2.  Metabolic Recovery of the Failing Heart: Emerging Therapeutic Options.

Authors:  Dale J Hamilton
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Jan-Mar

Review 3.  Pet Imaging and its Application in Cardiovascular Diseases.

Authors:  Zheng Li; Anisha A Gupte; Anjun Zhang; Dale J Hamilton
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Jan-Mar

Review 4.  Fuel availability and fate in cardiac metabolism: A tale of two substrates.

Authors:  Florencia Pascual; Rosalind A Coleman
Journal:  Biochim Biophys Acta       Date:  2016-03-16

Review 5.  Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg.

Authors:  Daniela Miranda-Silva; Tânia Lima; Patrícia Rodrigues; Adelino Leite-Moreira; Inês Falcão-Pires
Journal:  Heart Fail Rev       Date:  2021-01-07       Impact factor: 4.214

Review 6.  Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT.

Authors:  Ryogo Minamimoto
Journal:  Jpn J Radiol       Date:  2021-01-31       Impact factor: 2.374

7.  Metabolic remodeling precedes mTORC1-mediated cardiac hypertrophy.

Authors:  Giovanni E Davogustto; Rebecca L Salazar; Hernan G Vasquez; Anja Karlstaedt; William P Dillon; Patrick H Guthrie; Joseph R Martin; Heidi Vitrac; Gina De La Guardia; Deborah Vela; Aleix Ribas-Latre; Corrine Baumgartner; Kristin Eckel-Mahan; Heinrich Taegtmeyer
Journal:  J Mol Cell Cardiol       Date:  2021-06-01       Impact factor: 5.763

Review 8.  Strategies for Imaging Metabolic Remodeling of the Heart in Obesity and Heart Failure.

Authors:  Amier Haidar; Heinrich Taegtmeyer
Journal:  Curr Cardiol Rep       Date:  2022-02-02       Impact factor: 3.955

9.  Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction.

Authors:  Ailan Chen; Wanglin Li; Xinyu Chen; Yuechun Shen; Wenjun Dai; Qi Dong; Xinchun Li; Caiwen Ou; Minsheng Chen
Journal:  BMC Cardiovasc Disord       Date:  2016-11-17       Impact factor: 2.298

10.  QiShenYiQi Pill Improves Myocardial Hypertrophy Caused by Pressure Overload in Rats.

Authors:  Shichao Lv; Qiang Wang; Meifang Wu; Meng Li; Xiaojing Wang; Ling Xu; Junping Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.